Skip to main content

Case Comprehensive Cancer Center

Khalid%20Sossey-Alaoui.jpg
Sossey-Alaoui Receives $2.3M from NIH to Study Breast Cancer and Health Disparities in African-American Women
Khalid Sossey-Alaoui, PhD, member of Case CCC's Molecular Oncology Program, received a five-year, $2.3 million grant to study mechanisms mediating "triple-negative" breast cancer and health disparities in African-American women. Among genetically distinct breast cancers, those classified as…
1680548912682.jpg
Case CCC Research Teams Receive Awards
Teams from Case CCC and University Hospitals have received Collaborative Pilot Science Awards to conduct research on brain tumor, cerebral edema, and gastroesophageal cancer. Each team received $50,000 funded by the UH-CWRU Joint Strategic Leadership Committee. According to Daniel Simon, MD,…
Emerging%20Researchers.jpg
Emerging Researchers Program Kicks Off Second Year
The brainchild of John Wang, PhD, Co-Leader of Case CCC's Cancer Genomics and Epigenomics Program, the Emerging Researchers Program welcomed four returning students and two new students this week—all from East Cleveland. With the support of Frances Payne Bolton School of Nursing, CWRU's Faye…
image9.jpg
A new study published in NEJM Evidence with University Hospitals Seidman Cancer Center researchers and ArteraAI validates the first-ever predictive AI biomarker of androgen deprivation therapy (ADT) benefit in prostate cancer
University Hospitals Newsroom CLEVELAND – Data from a new study published in NEJM Evidence shows promise for personalized use of short term ADT in men with predominantly intermediate-risk prostate cancer. The study involved ArteraAI, a developer of multimodal artificial intelligence-based…
J.%20Alan%20Diehl.jpg
New $2.5M Stand Up To Cancer Grant Goes to Columbia-led Team for Clinical, Translational Esophageal Cancer Research
A new three-year, $2.5 million grant from Stand Up To Cancer® (SU2C) has been awarded to a multi-institutional team of gastroesophageal cancer experts, led by Anil K. Rustgi, MD, director of the Herbert Irving Comprehensive Cancer Center (HICCC) at NewYork-Presbyterian/Columbia University Irving…
SEO%3AYES%20Orientation.jpg
SEO and YES Programs Celebrate 20 Years
A standing-room-only audience of Cleveland high school students and their families attended orientation for the 20th Annual Scientific Enrichment and Opportunity (SEO) and Youth Engaged in Science (YES) programs on June 5. Students were treated to an inspirational and motivational address by Edward…
2023 CanSUR Scholars Ready to Rock and Roll this Summer
Case CCC proudly introduces the 2023 cohort of CanSUR Scholars. These diverse students from universities across the nation begin training in Cleveland at the end of May. Directed by Mark Jackson, PhD, Associate Director for Cancer Training and Education, the program this year attracted 320…
Exner Lab Improving Gene Therapy with Tiny Bubbles
Agata Exner, PhD, co-leader of Case CCC's Cancer Imaging Program and Associate Director of CWRU SOM's Medical Scientist Training Program, was featured in Newswise on April 11 with postdoc Pinunta "Petch" Nittayacharn for their work using tiny bubbles to make mRNA more effective. Nittayacharn…
Schwartz%20Airport.jpg
Cleveland Offers Up Hard-to-Miss Welcome for New Case CCC Director
Move over, Big Apple! While Cleveland might not have Times Square, it isn't lacking in the welcome department. Electronic billboards at Cleveland Hopkins International Airport greeted Gary Schwartz, MD, even before his official first day as Case CCC director. Schwartz, who hails from New York…
Quintin Pan's Research Makes Headline News
Research originating from the lab of Quintin Pan, PhD, co-leader of Case CCC's Molecular Oncology Program, was featured last week on cleveland.com. It was reported that the two drugs on which his lab is working are likely to stop HPV from causing cancer. Pan suggests that, even if the virus can't…